Delivery Order SPE2DB22D3301-SPE2DB25FY6SU
Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,963.08 firm fixed-price delivery order is for the supply of 4,568,093,069 units of the hepatitis A vaccine HAVRIX 1,440 UNIT/ML SYRINGE. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,576.04 Firm Fixed Price Delivery Order contract is for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has a period of performance through December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,833.31 firm fixed-price delivery order is for the procurement of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine, with a period of performance through March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a $20,172.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a $3,871.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,811.00 fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has a period of performance through September 16, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.28 firm-fixed-price contract is for the supply of HAVRIX 720 Unit/0.5 mL syringes, a hepatitis A vaccine. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.60 firm fixed-price delivery order is for the supply of 1,440 units of the Hepatitis A vaccine Havrix, with a completion date of September 22, 2021. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $5,501.10 contract is for the delivery of 1,440-unit/mL doses of the hepatitis A vaccine HAVRIX. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.60 firm fixed-price delivery order is for the supply of 1,440 units of the Hepatitis A vaccine HAVRIX. The award, which has no set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the...